Pharming Group (PHAR)
8.333
-0.19
(-2.20%)
USD |
NASDAQ |
Nov 04, 16:00
8.40
+0.07
(+0.81%)
After-Hours: 20:00
Pharming Group Revenue (Quarterly): 74.85M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 74.85M |
| June 30, 2024 | 74.09M |
| March 31, 2024 | 55.59M |
| December 31, 2023 | 81.22M |
| September 30, 2023 | 66.66M |
| June 30, 2023 | 54.90M |
| March 31, 2023 | 42.54M |
| December 31, 2022 | 54.62M |
| September 30, 2022 | 54.24M |
| June 30, 2022 | 50.15M |
| March 31, 2022 | 46.62M |
| December 31, 2021 | 52.77M |
| September 30, 2021 | 52.86M |
| June 30, 2021 | 49.67M |
| March 31, 2021 | 43.56M |
| December 31, 2020 | 54.01M |
| September 30, 2020 | 58.52M |
| June 30, 2020 | 45.27M |
| March 31, 2020 | 54.37M |
| December 31, 2019 | 54.42M |
| September 30, 2019 | 46.35M |
| June 30, 2019 | 49.06M |
| March 31, 2019 | 39.56M |
| December 31, 2018 | 40.37M |
| September 30, 2018 | 45.46M |
| Date | Value |
|---|---|
| June 30, 2018 | 32.39M |
| March 31, 2018 | 36.35M |
| December 31, 2017 | 40.91M |
| September 30, 2017 | 31.55M |
| June 30, 2017 | 18.54M |
| March 31, 2017 | 16.52M |
| December 31, 2016 | 6.944M |
| September 30, 2016 | 3.883M |
| June 30, 2016 | 3.357M |
| March 31, 2016 | 2.509M |
| December 31, 2015 | 2.292M |
| September 30, 2015 | 3.675M |
| June 30, 2015 | 3.944M |
| March 31, 2015 | 1.928M |
| December 31, 2014 | 20.89M |
| September 30, 2014 | 1.412M |
| June 30, 2014 | 1.512M |
| March 31, 2014 | 1.952M |
| December 31, 2013 | 1.399M |
| September 30, 2013 | 1.670M |
| June 30, 2013 | 5.762M |
| March 31, 2013 | 0.6198M |
| December 31, 2012 | 11.15M |
| September 30, 2012 | 0.6533M |
| June 30, 2012 | 1.064M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
42.54M
Minimum
Mar 2023
81.22M
Maximum
Dec 2023
56.05M
Average
54.30M
Median
Revenue (Quarterly) Benchmarks
| uniQure NV | 11.13M |
| ProQR Therapeutics NV | 6.789M |
| Merus NV | 11.77M |
| argenx SE | 573.24M |
| Pharvaris NV | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.034M |
| Total Expenses (Quarterly) | 70.74M |
| EPS Diluted (Quarterly) | -0.02 |
| Enterprise Value | 488.90M |
| Gross Profit Margin (Quarterly) | 90.89% |
| Profit Margin (Quarterly) | -1.38% |
| Earnings Yield | -3.24% |
| Normalized Earnings Yield | -3.244 |